A compound in pomegranates can trigger cancer cell death
(Natural News) The interest in fruits rich in polyphenols has recently increased due to their cancer-fighting potential. In a study published in the journal Nutrition Research, a team of researchers from China found that a compound in pomegranates called punicalagin can fight against cancer by triggering cancer cell death. A previous study carried out by... (Source: NaturalNews.com)
Source: NaturalNews.com - May 10, 2019 Category: Consumer Health News Source Type: news

ACS Sets Goal to Cut Cancer Mortality 40 Percent by 2035
Goal based on decrease in overall cancer death rates at pace seen among college graduates (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - May 10, 2019 Category: Cancer & Oncology Tags: Dermatology, Gastroenterology, Gynecology, Nephrology, Oncology, Ophthalmology, ENT, Pediatrics, Pulmonology, Radiology, Surgery, Urology, Journal, Source Type: news

Cover Up! Don't Soak Up Those Sun Rays
(Source: Cancercompass News: Other Cancer)
Source: Cancercompass News: Other Cancer - May 10, 2019 Category: Cancer & Oncology Source Type: news

Judge: Boy must resume chemotherapy, despite parents' wishes
A judge has ruled that a 3-year-old Florida boy must resume his cancer treatment, despite his parents' wishes (Source: ABC News: Health)
Source: ABC News: Health - May 10, 2019 Category: Consumer Health News Tags: Health Source Type: news

True Cancer Bodies: 'Adverts don't show how traumatic cancer is'
The True Cancer Bodies campaign was set up after what campaigners said were "misleading" adverts. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - May 10, 2019 Category: Consumer Health News Source Type: news

Prostate cancer warning: This sleep habit could double your risk of deadly condition
PROSTATE cancer is the most common cancer in men in the UK, with age, ethnicity and obesity all being risk factors. But a new study has suggested a certain sleep habit can almost double your risk of the condition developing. (Source: Daily Express - Health)
Source: Daily Express - Health - May 10, 2019 Category: Consumer Health News Source Type: news

Latest NHS performance figures dubbed ‘shocking’
Thousands left waiting on trolleys and chairs Related items fromOnMedica Eight in ten stillbirths might have been avoided NHS lagging on preventing cancer and heart deaths Day surgery shake-up for Northern Ireland Care to be delivered ‘closer to home,’ says Welsh government Conditions in the NHS have worsened, new report shows (Source: OnMedica Latest News)
Source: OnMedica Latest News - May 10, 2019 Category: UK Health Source Type: news

Green light for primary progressive MS drug
NICE reverses its decision on ocrelizumab Related items fromOnMedica Clinicians need better options if we are to stop over-medication Call for NHS England to ‘think again’ on limiting treatment Wales cancer spend at record high Resources wasted on low-risk blood pressure patients NHS saves £324m by switching to cheaper medicines (Source: OnMedica Latest News)
Source: OnMedica Latest News - May 10, 2019 Category: UK Health Source Type: news

Living With Cancer: Understanding thyroid cancer
Thyroid cancer Thyroid cancer occurs in the cells of the thyroid, a butterfly-shaped gland located at the base of your neck. Your thyroid produces hormones that regulate your heart rate, blood pressure, body temperature and weight. Thyroid cancer isn't common in the U.S., and there may be no signs or symptoms early in the disease. [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - May 10, 2019 Category: Databases & Libraries Source Type: news

A California teacher on medical leave for breast cancer has to pay for her substitute
A San Francisco teacher who is on medical leave has to worry about more than just battling breast cancer. (Source: CNN.com - Health)
Source: CNN.com - Health - May 9, 2019 Category: Consumer Health News Source Type: news

Servier launches U.S. cancer business with plans to double headcount in next 5 years
France ’s second-largest pharmaceutical company, Servier Group, opened its first U.S.-based commercial subsidiary in Boston this week, with plans to double the headcount over the next five years. Servier Pharmaceuticals opened its doors at 200 Pier 4 Blvd. Thursday. The 14,500-square-foot site will hous e Servier's work developing and commercializing treatments for gastrointestinal and liquid cancers like leukemia using immune system-leveraging approaches including CAR-T and monoclonal antibodies.… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - May 9, 2019 Category: Pharmaceuticals Authors: Allison DeAngelis Source Type: news

Servier launches U.S. cancer business with plans to double headcount in next 5 years
France ’s second-largest pharmaceutical company, Servier Group, opened its first U.S.-based commercial subsidiary in Boston this week, with plans to double the headcount over the next five years. Servier Pharmaceuticals opened its doors at 200 Pier 4 Blvd. Thursday. The 14,500-square-foot site will hous e Servier's work developing and commercializing treatments for gastrointestinal and liquid cancers like leukemia using immune system-leveraging approaches including CAR-T and monoclonal antibodies.… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 9, 2019 Category: Biotechnology Authors: Allison DeAngelis Source Type: news

ARRS: Cinematic rendering comes to breast ultrasound
HONOLULU - Researchers from California produced photorealistic 3D models of...Read more on AuntMinnie.comRelated Reading: 3 ways cinematic rendering helps visualize the spleen Cinematic rendering makes strides in cancer evaluation Cinematic rendering paves way for 'virtual' physical exam Cinematic rendering enhances pelvic CT bone evaluation Cinematic rendering enhances ovarian cancer evaluation (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - May 9, 2019 Category: Radiology Source Type: news

ACS Sets Goal to Cut Cancer Mortality 40 Percent by 2035
THURSDAY, May 9, 2019 -- The American Cancer Society (ACS) has set a goal of a 40 percent reduction in overall cancer mortality by 2035, according to a study published online May 8 in CA: A Cancer Journal for Clinicians. Jiemin Ma, Ph.D., from the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 9, 2019 Category: Pharmaceuticals Source Type: news

J & amp;J & #039;s Ethicon Spends $400M for Takeda ’s Fibrin Sealant Patch
Johnson & Johnson’s Ethicon is set to acquire Takeda Pharmaceutical’s Fibrin Sealant Patch for $400 million. The deal is set to close in the second half of 2019. The TachoSil is a surgical patch designed to achieve safe fast and reliable bleeding control. Upon close, about 80 employees will transition to Ethicon. Takeda said net sales for TachoSil were about $155 million for the 2018 fiscal year. Terms for the deal call for Ethicon to acquire the assets and licenses that support the manufacturing, licensing and commercialization of TachoSil, while Takeda maintains ownership of the ma...
Source: MDDI - May 9, 2019 Category: Medical Devices Authors: Omar Ford Tags: Business Source Type: news

Men spared from chemotherapy as NHS adopts 'active surveillance' for prostate cancer patients
Active surveillance is a way of monitoring prostate cancer using blood tests and scans every few months. NHS doctors in England will now recommend it to patients with localised cancer. (Source: the Mail online | Health)
Source: the Mail online | Health - May 9, 2019 Category: Consumer Health News Source Type: news

Chemotherapy demand will rise 50% by 2040, study says
By 2040, the number of people worldwide who will need chemotherapy to treat cancer could grow to 15 million. (Source: Health News - UPI.com)
Source: Health News - UPI.com - May 9, 2019 Category: Consumer Health News Source Type: news

Fifteen Million Patients Will Need First - Course Chemo in 2040
Number of cancer physicians required to deliver optimal chemo set to increase to 100,000 by 2040 (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - May 9, 2019 Category: Cancer & Oncology Tags: Family Medicine, Gastroenterology, Gynecology, Internal Medicine, Oncology, Pharmacy, Pulmonology, Journal, Source Type: news

Mammo - Based Deep Learning Model Assesses Breast Cancer Risk
Deep learning models more accurate than models that use traditional risk factors, breast density (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - May 9, 2019 Category: Cancer & Oncology Tags: Gynecology, Oncology, Radiology, Journal, Source Type: news

Radiation Therapy Consent Forms Too Difficult to Read Radiation Therapy Consent Forms Too Difficult to Read
Cancer patients usually get written consent forms to sign before radiation that are supposed to clearly spell out the treatment risks, but a new U.S. study suggests these forms are too complex for most patients to easily understand.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 9, 2019 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Nigeria: Tips From Nigeria On Teaching Teens About Breast and Cervical Cancer
[The Conversation Africa] Globally, one in six women will develop cancer in her lifetime, and one in 11 will die. Incidences of cancer are lower in women in developing countries, but they have higher cancer deaths rates than women in the developed world. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - May 9, 2019 Category: African Health Source Type: news

Statins may reduce death risk from colorectal cancer
People who already used statins before receiving a colorectal cancer diagnosis had an 18 percent lower risk of dying from cancer (Source: Health News - UPI.com)
Source: Health News - UPI.com - May 9, 2019 Category: Consumer Health News Source Type: news

Wake-up Call: Global Demand for Chemo Will Double by 2040 Wake-up Call: Global Demand for Chemo Will Double by 2040
In the near future, countries around the world will face serious problems in their ability to deliver chemotherapy to cancer patients.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 9, 2019 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

BMS ’s Opdivo stumbles in late-stage cancer trial
The immuno-oncology treatment recently hit a roadblock in a trial targeting patients with glioblastoma multiforme. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - May 9, 2019 Category: Pharmaceuticals Source Type: news

A&E and cancer performance hit record lows
The English NHS produced a record low performance against key treatment targets in April, official statistics have today revealed. (Source: HSJ)
Source: HSJ - May 9, 2019 Category: UK Health Source Type: news

NHS crisis: Record 4.23million people are on the waiting list for routine ops
NHS figures for England today revealed a record 70,403 visits were made to A&E departments on an average day in April and in 2017/18 only 79.1 per cent of cancer patients were treated within two months. (Source: the Mail online | Health)
Source: the Mail online | Health - May 9, 2019 Category: Consumer Health News Source Type: news

Study: Childhood inflammatory bowel disease raises cancer risk in adulthood
People had a 2.5 times higher risk of developing cancer if they had ulcerative colitis before they turned 18, new research shows. (Source: Health News - UPI.com)
Source: Health News - UPI.com - May 9, 2019 Category: Consumer Health News Source Type: news

BioLegend Moves Global Headquarters to Newly Constructed, State-of-the-Art Campus in San Diego, California
BioLegend Campus Inauguration Symposium focused on Cancer Immunotherapy features Nobel Laureate and World-Renowned Immunologists (Source: The Scientist)
Source: The Scientist - May 9, 2019 Category: Science Tags: The Scientist The Marketplace Source Type: news

Karmanos pancreatic cancer research gains support from golf outing
(Source: Karmanos Cancer Institute)
Source: Karmanos Cancer Institute - May 9, 2019 Category: Cancer & Oncology Source Type: news

Katie Couric says there hasn't been enough change since #MeToo
In her 40 years in television news, award-winning journalist Katie Couric has been a prominent voice on the national stage. In 2000, she had a colonoscopy on live TV to raise awareness about colon cancer after her husband Jay died of the disease. Couric lost her sister Emily in 2001 to pancreatic cancer. Now, she is partnering with a new program called "With Love, Me." It asks people, whose lives have been affected by cancer what they wish they had known when they first heard their diagnosis. Couric joins "CBS This Morning" to discuss her new partnership and how the media landscape has changed. (Source:...
Source: Health News: CBSNews.com - May 9, 2019 Category: Consumer Health News Source Type: news

Anger is more damaging to health than sadness in old age, study says
Losing mobility, friends, and the ability to do things as before can fuel anger, which fuels inflammation which can cause heart disease, cancer and arthritis. Experts say the risk is underappreciated. (Source: the Mail online | Health)
Source: the Mail online | Health - May 9, 2019 Category: Consumer Health News Source Type: news

Varian and Shandong Cancer Hospital Form Proton Therapy Clinical Application and Research Partnership in China
PALO ALTO, Calif. and JINAN, China, May 9, 2019 -- (Healthcare Sales & Marketing Network) -- Varian (NYSE: VAR) today announced it has signed a strategic cooperation framework agreement with Shandong Cancer Hospital in China, for proton therapy clinical a... Devices, Oncology Varian Medical Systems, ProBeam, proton therapy, radiotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 9, 2019 Category: Pharmaceuticals Source Type: news

Risk for Cancer Increased in Men, Women With T2DM
THURSDAY, May 9, 2019 -- Men and women with type 2 diabetes (T2D) have an increased risk for overall cancer and some site-specific cancers, according to a study published online May 9 in the Journal of Diabetes. Jiying Qi, from the Shanghai Jiao... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 9, 2019 Category: Pharmaceuticals Source Type: news

Fifteen Million Patients Will Need First-Course Chemo in 2040
THURSDAY, May 9, 2019 -- An estimated 15.0 million patients will require first-course chemotherapy in 2040, with delivery requiring 100,000 cancer physicians, according to a study published online May 8 in The Lancet Oncology. Brooke E. Wilson, from... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 9, 2019 Category: Pharmaceuticals Source Type: news

Mammo-Based Deep Learning Model Assesses Breast Cancer Risk
THURSDAY, May 9, 2019 -- Mammography-based deep learning (DL) breast cancer risk models are more accurate than models that consider traditional risk factors and breast density, according to a study published online May 7 in Radiology. Adam Yala,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 9, 2019 Category: Pharmaceuticals Source Type: news

Bristol-Myers' Opdivo fails late-stage brain cancer trial
Bristol-Myers Squibb Co said on Thursday its immunotherapy Opdivo failed to meet the main goal of a late-stage trial testing it in patients with an aggressive form of tumor that affects the brain or the spine. (Source: Reuters: Health)
Source: Reuters: Health - May 9, 2019 Category: Consumer Health News Tags: healthNews Source Type: news

Moffitt lands among the top 5 hospital and health systems for diversity
Moffitt Cancer Center in Tampa has been recognized by DiversityInc as one of the nation's top hospitals and health systems for diversity. Florida's largest cancer center moved up to No. 3 in its fourth year appearing on the list. It was the only one in Florida to make the list. The Cleveland Clinic and Northwell Health placed first and second, respectively. DiversityInc considers four areas of diversity management for its list: s upplier diversity, talent pipeline, talent development and leadership… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 9, 2019 Category: Biotechnology Authors: Pam Huff Source Type: news

CNN admits the Health Ranger has been right all along: Sunscreen chemicals are absorbed into your bloodstream where they can promote cancer
(Natural News) The Center for Drug Evaluation and Research (CDER), a branch of the U.S. Food and Drug Administration (FDA), has published the results of a pilot study looking at the safety of many common sunscreen products – and what was discovered is that sunscreen chemicals absorb into the bloodstream via the skin in a... (Source: NaturalNews.com)
Source: NaturalNews.com - May 9, 2019 Category: Consumer Health News Source Type: news

Low uptake of cancer risk assessment tools in primary care
Many GP practices are failing to make use of potentially life-saving risk assessment tools that can help catch cancer early on, suggests a new study. (Source: Nursing Times)
Source: Nursing Times - May 9, 2019 Category: Nursing Source Type: news

Is shared decision-making CT lung screening's Trojan horse?
Has the requirement that high-risk individuals complete a shared decision-making...Read more on AuntMinnie.comRelated Reading: Doctors continue to forgo CT lung screening discussions Can videos convince smokers to get CT lung screening? New decision aids may revamp CT lung cancer screening Second Opinion: Medicare CT screening decision raises questions CT lung screening meeting: A travesty of public health policy (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - May 9, 2019 Category: Radiology Source Type: news

South Africa: Shots, Myths & Cash - the Perilous Road to Curbing Cancer
[Bhekisisa] Before 2011, this country couldn't screen for cervical cancer let alone prevent it. Since then everything's changed. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - May 9, 2019 Category: African Health Source Type: news

Kenya: Collymore, Mercy Oburu Appointed to National Cancer Institute Board
[Nairobi News] Safaricom CEO Bob Collymore and Royal Media Services head of digital content Mercy Oburu have been appointed to the board of the National Cancer Institute. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - May 9, 2019 Category: African Health Source Type: news

Biomarker may help identify men with prostate cancer at greater risk of tumor metastasis
(Elsevier) Ten percent of patients with prostate cancer develop locally invasive and metastatic disease, which increases the severity of the disease and likelihood of death and limits treatment options. A report in The American Journal of Pathology indicates that a significantly lower presence of syntaphilin (SNPH) -- a mitochondrial protein -- within the tumor's central core versus at the tumor's invasive outer edge, may identify patients at increased risk of metastasis. These patients may require more rigorous testing, surveillance, and treatment. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 9, 2019 Category: International Medicine & Public Health Source Type: news

Diabetes linked to numerous cancers in large Chinese study
(Wiley) A new Journal of Diabetes study from China, which has the highest number of people with diabetes among all countries, found that type 2 diabetes was linked with an elevated risk of 11 types of cancer in men and 13 types of cancer in women. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 9, 2019 Category: International Medicine & Public Health Source Type: news

New treatment could become first targeted therapy designed for 'untreatable' childhood brain cancer
(Institute of Cancer Research) A new type of drug that targets a genetic weakness in an untreatable childhood brain cancer could become the first ever treatment designed to target the disease.The prototype treatment could also offer hope for patients with the rare and devastating 'stone man syndrome' -- in which muscles and ligaments turn to bone. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 9, 2019 Category: International Medicine & Public Health Source Type: news

Statins linked to lower risk of early death in patients with colorectal cancer
(Wiley) Use of statins before or after a diagnosis of colorectal cancer was linked with a lower risk of premature death, both from cancer and from other causes, in a Cancer Medicine analysis of published studies. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 9, 2019 Category: International Medicine & Public Health Source Type: news

Fracture risk tool useful in women with breast cancer initiating aromatase inhibitor therapy
(Wiley) The FRAX ® tool takes into account certain factors to determine the risk of bone fracture in the general population. In a Journal of Bone and Mineral Research study, the tool was effective at determining fracture risk for women with breast cancer who were treated with aromatase inhibitors, which cause accelerated bone loss, when combined with bone mineral density measurements. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 9, 2019 Category: International Medicine & Public Health Source Type: news

Inflammatory bowel disease during childhood linked to higher cancer rates and early death
(Wiley) A new Alimentary Pharmacology& Therapeutics study revealed an increased risk of cancer and early death in individuals who developed inflammatory bowel disease-including ulcerative colitis (UC) and Crohn's disease (CD) -- during childhood. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 9, 2019 Category: International Medicine & Public Health Source Type: news

How genomics profiling can help identify the best treatment for bladder cancer
(Baylor College of Medicine) A new computational tool -- a single-patient classifier -- effectively enables physicians to assign a bladder cancer subtype to an individual patient's cancer using that patient's genomic data. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 9, 2019 Category: Cancer & Oncology Source Type: news

North York General study shows safest method for prostate cancer biopsies
(North York General Hospital) Only one percent of testing for prostate cancer in North America is done using TPBx. North York General Hospital has shown this to be the safest method and can be performed under local anesthetic. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 9, 2019 Category: Cancer & Oncology Source Type: news